Live Breaking News & Updates on Catalent Pharma Solutions Inc

Stay updated with breaking news from Catalent pharma solutions inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Exelixis (NASDAQ:EXEL) vs. Editas Medicine (NASDAQ:EDIT) Head-To-Head Review

Exelixis (NASDAQ:EXEL – Get Free Report) and Editas Medicine (NASDAQ:EDIT – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, dividends, profitability, risk and valuation. Analyst Recommendations This is a summary of recent ratings […] ....

United States , United Kingdom , Daiichi Sankyo Company , Takeda Pharmaceutical Company Ltd , Invenra Inc , Stemsynergy Therapeutics Inc , Rp Scherer Technologies , Bristol Myers Squibb Company , Juno Therapeutics Inc , Exelixis Inc , Allergan Pharmaceuticals International , Iconic Therapeutics Inc , Aurigene Discovery Technologies , Roche Ltd , Exelixis Pharmaceuticals Inc , Redwood Bioscience Inc , Genentech Inc , Gengine Inc , Catalent Pharma Solutions Inc , Editas Medicine Inc , Get Free Report , Editas Medicine , Given Editas Medicine , Ipsen Pharma , Redwood Bioscience , Catalent Pharma Solutions ,

Catalent Announces Closing of Incremental Term Loans

Catalent Announces Closing of Incremental Term Loans
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New Jersey , United States , Paul Surdez , Catalent Pharma Solutions Inc , Catalent Inc , Catalent Pharma Solutions , Matti Masanovich , Chief Financial , Private Securities Litigation Reform Act , Annual Report ,

Catalent Announces Closing of Incremental Term Loans

Catalent, Inc. , the leader in enabling the development and supply of better treatments for patients worldwide, announced today that its wholly owned subsidiary, Catalent Pharma Solutions, Inc., as. ....

New Jersey , United States , Catalent Inc , Catalent Pharma Solutions Inc , Catalent Pharma Solutions , Matti Masanovich , Chief Financial , Private Securities Litigation Reform Act , Annual Report ,